HomeTherapeutic areas › Cardiovascular

Cardiovascular (18 companies · 22 conditions)

Conditions

Companies

Ticker Company Therapeutic areas In Cardiovascular Lead stage Programs
BIOA BioAge Labs CardiovascularOphthalmology 1 Phase 2 2
CRDL Cardiol Therapeutics Cardiovascular Rare 4 Phase 3 4
EXEL Exelixis CardiovascularOncology 1 Approved 22
GOSS Gossamer Bio Cardiovascular Rare 4 Phase 3 4
INSM Insmed CardiovascularDermatology+2 Rare 2 Approved 9
NTLA Intellia Therapeutics CardiovascularImmunology Rare 2 NDA Submitted 3
LXEO Lexeo Therapeutics CardiovascularNeurology Rare 3 Phase 1 8
LGVN Longeveron CardiovascularMetabolic+1 Rare 2 Phase 2 4
MIST Milestone Pharmaceuticals Cardiovascular 2 Approved 2
GLUE Monte Rosa Therapeutics CardiovascularDermatology+2 Rare 1 Phase 2 6
NAMS NewAmsterdam Pharma CardiovascularMetabolic+1 3 NDA Submitted 6
RVPH Reviva Pharmaceuticals CardiovascularDermatology+2 Rare 1 Phase 3 10
RCKT Rocket Pharmaceuticals CardiovascularImmunology Rare 3 Approved 4
SLDB Solid Biosciences CardiovascularNeurology Rare 4 Phase 3 6
TECX Tectonic Therapeutic Cardiovascular Rare 3 Phase 2 3
TENX Tenax Therapeutics Cardiovascular Rare 2 Phase 3 2
RARE Ultragenyx Pharmaceutical CardiovascularGI/Hepatology+2 Rare 1 Approved 12
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved 29